Almond Consumption for 8 Weeks Altered Host and Microbial Metabolism in Comparison to a Control Snack in Young Adults

Almond consumption can improve cardiometabolic (CM) health. However, the mechanisms underlying those benefits are not well characterized. This study explored the effects of consuming a snack of almonds vs. crackers for 8 weeks on changes in metabolomic profiles in young adults (clinicaltrials.gov ID: NCT03084003). Participants (n=73, age: 18-19 years, BMI: 18-41 kg/m2) were randomly assigned to consume either almonds (2 oz/d, n=38) or an isocaloric control snack of graham crackers (325 kcal/d, n=35) daily for 8 weeks. Blood samples were collected at baseline prior to and at 4 and 8 weeks after the intervention. Metabolite abundances in the serum were quantified by hydrophilic interaction chromatography quadrupole (Q) time-of-flight (TOF) mass spectrometry (MS/MS), gas chromatography (GC) TOF MS, CSH-ESI (electrospray) QTOF MS/MS, and targeted analyses for free PUFAs, total fatty acids, oxylipins and endocannabinoids. Linear mixed model analyses with baseline-adjustment were conducted, and those results were used for enrichment and network analyses. Microbial community pathway predictions from 16S rRNA sequencing of fecal samples was done using PICRUST2. Almond consumption enriched unsaturated triglycerides, unsaturated phosphatidylcholines, saturated and unsaturated lysophosphatidylcholines, tricarboxylic acids, and tocopherol clusters (p<0.05). Targeted analyses reveal lower levels of omega-3 total fatty acids (TFAs) overall in the almond group compared to the cracker group (p<0.05). Microbial amino acid biosynthesis, and amino sugar and nucleotide sugar metabolism pathways were also differentially enriched at the end of the intervention (p<0.05). The study demonstrates the differential effects of almonds on host tocopherol, lipid, and TCA cycle metabolism with potential changes in microbial metabolism, which may interact with host metabolism to facilitate the CM benefits.

The complex interplay among the host genome, the gut microflora, and environmental Surrogate recoveries were between 28 -108% for all oxylipin and endocannabinoid 2 5 1 analytes and 54% for fatty acids. Analytical precision was assessed by duplicate analysis of a 2 5 2 plasma pool control (UTAK) (n=20) and was excellent with 83% of oxylipin and UTAKs analyzed, respectively. identifiers. The targeted analyses detected and quantified 23 total fatty acids, 29 oxylipins, 10 2 6 1 endocannabinoids, and 5 non-esterified PUFAs above the limits of detection. In total, 692 2 6 2 metabolites were uniquely identified after removal of duplicates and quality checks.  The means of those untargeted metabolites that had baseline-adjusted snack and snack x time p-values <0.05 are shown in Table 1. Almond consumption resulted in overall greater levels 2 6 8 of alpha-tocopherol, ecgonine, erucic acid, indole-3-carboxaldehyde,  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021. ;

12
Several metabolites depicted significant snack and time interactions (baseline-2 7 3 adjusted snack x time effect, p<0.05, Table 1). Contrasts depict that cracker consumption 2 7 4 resulted in greater levels of isomaltose at week 4 compared to week 8 (p<0.05). Almond  The means of specific targeted metabolites that showed significant (p<0.05) baseline-  ChemRICH analysis, which was conducted on baseline-adjusted metabolite values, 2 9 0 mapped 625 of the identified (untargeted) metabolites to 58 non-overlapping chemical 2 9 1 classes. Seven clusters were significantly different between the almond and cracker groups 2 9 2 (FDR-adjusted p-value < 0.05) overall. Almond consumption enriched unsaturated 2 9 3 triglycerides, unsaturated phosphatidylcholines, saturated and unsaturated 2 9 4 lysophosphatidylcholines, sphingomyelins, and tricarboxylic acids clusters. The key 2 9 5 metabolites in each of those clusters are depicted in Table 3. The tocopherol cluster was also 2 9 6 influenced with almond consumption overall (FDR-adjusted p-value <0.05) with gamma-2 9 7 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 5, 2021. ; 2 9 8 cracker consumption (Table 3). The almond group had greater levels of metabolites involved in the TCA cycle such as succinic, aconitic, and isocitric acids, and lower levels of hexitol compared to cracker  2-alpha-mannobiose (g=0.28) at week 8 and lower levels of ribonic acid at week 4 (g=0.24) 3 1 4 compared to cracker consumption (time x snack effect, p<0.05). Almond consumption largely elicited lower levels of metabolites involved in amino acid metabolism such as cyclo (Leu-Pro), alpha-methyl-histidine, and pipecolinic acid (g=0.31-0.65) and higher levels of phenylacetylglutamine (g=0.27) and indole-3-3 2 0 carboxaldehyde (g=0.56) compared to cracker consumption (snack effect, p<0.05).

2 1
Differential time x snack effects (p<0.05) were noted as well with 4-acetamidobutyric acid, CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 5, 2021. ; alpha-keto-gamma-(methylthio) butyric acid, and oxoproline lower with almond consumption 3 2 3 at week 8 (g=0.27-0.39) but not at week 4. N-acetylglycine was greater in the almond group  The alterations in lipid metabolites such as LPC, PC, TG, and SM, and fatty acids and their derivatives with almond consumption have been described in the previous sections. palmitoylcarnitine (g=0.31), which was increased in the almond group (snack effect, p<0.05).

2
Differential time x snack effects (p<0.05) were noted for acetylcarnitine (g=0.47) and   Almond consumption elicited greater levels of alpha-tocopherol (g=0.49) and lower 3 3 9 levels of gamma-tocopherol (g=0.53) and trigonelline (g=0.56) overall compared to cracker  Almond consumption elicited lower levels of 7-methylguanosine overall (g=0.37,  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.   Almond consumption generally increased unsaturated triglycerides over 8 weeks. More specifically, the almond group had higher levels of oleamide, which is a fatty acid 4 1 5 amide of oleic acid. Surprisingly, the targeted analyses did not detect a difference in oleic 4 1 6 acid TFA between groups even though it is the most predominant fatty acid in almonds. However, this inconsistency has been documented previously. For example, in a dose-4 1 8 dependent study, half-dose almonds (37 ± 2 g/d) increased oleic acid in NEFA and TAG fractions; however, the full dose (75 ± 3 g/d) did not demonstrate an increase in NEFA CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021. ; compared to the cracker group. The bioaccessibility of lipids from whole almonds during 4 2 2 mastication and digestion may limit the amount of fat absorbed through the gastrointestinal  Almond consumption also lowered the palmitoleic acid: palmitic acid ratio. A greater 4 3 5 ratio is considered a diagnostic marker for early onset non-alcoholic steatohepatitis (61) and  The targeted analysis reveals lower levels of omega-3 total fatty acids (TFAs) in the  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021. ; These discrepancies could be due to the low reproducibility of food omega-3 fatty acids by  The increases in aconitic, citric, isocitric, and succinic acids suggests that almond Mediterranean diet, a diet high in unsaturated fats, appeared to alleviate this risk (67). As cycle activity may be facilitated by increased acetylcarnitine. These data provide a improve glucose metabolism (via enhanced TCA cycle activity). In the same subjects studied here, almond consumption improved glucose tolerance (21). Another carnitine derivative, 3-hydroxyisovaleroylcarnitine, which is a degradation 4 6 9 byproduct of ketogenic amino acids, was lower in the almond group. This may suggest that 4 7 0 biotin intake was increased. Increased circulating levels of 3-hydroxyisovaleroylcarnitine is CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021. ; https://doi.org/10.1101/2021.05.03.21256353 doi: medRxiv preprint associated with impaired leucine catabolism due to reduced activity of 3-methylcrotonyl-CoA 4 7 2 carboxylase, which is a biotin-dependent enzyme in asymptomatic, marginally biotin biotin-rich foods (red meat and eggs) was increased in the almond group. We have previously documented increased alpha-diversity of the gut microbiome with glutamate, glutamine, tryptophan, phenylalanine, and proline (Supplemental Table 2). phenylacetylglutamine with alpha-diversity (72), which is supported by our study as well 4 9 9 (data not shown). Pipecolic acid, which was lower in the almond group, could arise from food 5 0 0 intake or produced by gut bacteria on lysine degradation (74). Although, cyclo (Leu-Pro) is a 5 0 1 bacterium-derived dipeptide whose functional role isn't well known, literature suggests that carboxaldehyde, which is a tryptophan metabolite that acts as a ligand for the aryl  We used comprehensive analyses to study the serum metabolome of almond versus the metabolomics data. However, since we used prediction models for assessing microbial limitations of KEGG database for lipidomic datasets. Nonetheless, these data provide previously explored. Future analyses will explore effects of factors such as BMI, sex, and metabolic risk on these outcomes. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021. ; Endocannabinoids. PLOS ONE 2012;7:e48852.                    is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021. b Untransformed means ± standard deviation is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021.  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021.   .

CC-BY 4.0 International license
It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021.     . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021. not have KEGG identifiers are included as independent nodes with manually annotated edges in their respective pathway clusters. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 5, 2021. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 5, 2021. ;